MannKind Corporation Expects FDA to Approve Inhaled Insulin; CEO Expects Approval "Within Days" of Plant Inspection
Reuters -- MannKind Corp expects the U.S. Food and Drug Administration to approve its experimental inhaled insulin device "within days" of inspecting a manufacturing plant that supplies the insulin, the company's chief executive said on Tuesday.